首页 > 专栏 > The Lancet Respiratory Medicine The Lancet Respiratory Medicine 共 38 条资讯 [Comment] The loud silence of subclinical tuberculosis: time to rethink tuberculosis infection-to-disease trajectories 2026-06-28 11:50:22 [Articles] PET–CT benchmarked detection and 5-year progression of asymptomatic tuberculosis: a longitudinal, prospective cohort study 2026-06-28 11:50:22 [Comment] Real-time subphenotyping in acute respiratory distress syndrome: a step towards precision medicine 2026-06-28 11:50:22 [Articles] Bedside identification of subphenotypes in acute respiratory failure (PHIND): a multicentre, observational cohort study 2026-06-28 11:50:22 [Spotlight] Russell Winwood: “COPD Athlete” defying views on lung disease 2026-06-28 11:50:22 [News] Local coalitions track pollution in neglected US communities 2026-06-28 11:50:22 [Comment] Precision medicine—a new era for the management of drug-resistant tuberculosis 2026-06-28 11:50:22 [Articles] Whole genome sequencing precision medicine strategy to shorten treatment for rifampicin-resistant tuberculosis (SMARTT): a pragmatic, randomised, single-blind phase 4 trial 2026-06-28 11:50:22 [News] SCCM 2026 guidelines: caring for older adults in the ICU 2026-06-28 11:50:22 [Review] Contributors to the heterogeneity of response to CFTR modulators 2026-06-28 11:50:22 [Articles] Non-invasive respiratory supports and criteria for intubation in randomised trials of acute hypoxaemic respiratory failure: a systematic review and network meta-analysis 2026-06-28 11:50:22 [Comment] Children's respiratory health risks in the Gaza war: a call to act 2026-06-28 11:50:22 [Comment] Non-invasive respiratory support improves outcomes in high-income countries 2026-06-28 11:50:22 [Comment] Emulating target trials to study ICU interventions 2026-06-28 11:50:22 [Comment] Azurocidin-1 in neutrophilic airway disease: marker, mediator, or bridge to precision therapy? 2026-06-28 11:50:22 [Articles] Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort study 2026-06-28 11:50:22 [Comment] Ventilator-associated risk beyond PARDS: insights from PRoVENT-PED 2026-06-28 11:50:22 [Articles] Epidemiology, ventilation management, and clinical outcomes in children (PRoVENT-PED): first results from the 10-year, investigator-initiated, international, multicentre, prospective cohort study 2026-06-28 11:50:22 [Review] Respiratory infections due to human common cold coronaviruses, SARS-CoV, MERS-CoV, and SARS-CoV-2: epidemiology, pathogenesis, clinical features, diagnostics, therapeutics, and vaccine landscapes 2026-06-28 11:50:22 [News] Barriers limit oxygen therapy in Nigeria, Kenya, and Uganda 2026-06-28 11:50:22 12下一页 » 相关分类 The Lancet Respiratory Medicine The Lancet #!/slash/note #UNTAG (B)(F)uzzing on my world (Hi)story (IN)SECURE Magazine Notification (gdb) break *0x972 - 带鱼博客 BeltfishBlog - ./kwaa.dev .NET Blog .Trash /home/rook1e 00's Adventure 0kami's Blog 0x41414141 in ?? () 0x7f Blog 0xRick Owned Root ! 0xd00's blog 1 Byte 1A23 Blog 1A23 Studio 1Link.Fun 1stwebdesigner 251 2BAB 的工程博客 2ch中文网 360 CERT 360 Netlab Blog - Network Securi 38号车评中心